Unified Patent Court (UPC) analytics are now available. Check here

TechnologyPatent OppositionCompetitive Analysis

In the competitive field of Nucleosides, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Nucleosides technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Nucleosides

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Nucleosides industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Nucleosides industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Nucleosides industry

EP3438116Labelled NucleotidesILLUMINA CAMBRIDGENov 17, 2021LATVIA MGI TECH SIA
EP2399588Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral PolymeraseMERCK SHARP & DOHMEJan 7, 2021GILEAD SCIENCES
EP2752488Antisense DesignROCHE INNOVATION CENTER COPENHAGENNov 12, 2020IONIS PHARMACEUTICALS
EP3363809Modified Nucleotides For Polynucleotide SequencingILLUMINA CAMBRIDGEAug 24, 2020LATVIA MGI TECH SIA
EP3587433Modified NucleotidesILLUMINA CAMBRIDGEAug 24, 2020LATVIA MGI TECH SIA
EP3002289Modified Nucleotides For Polynucleotide SequencingILLUMINA CAMBRIDGEApr 29, 2020MGI TECH HONG KONG
EP1633766Modified Fluorinated Nucleoside AnaloguesPHARMASSETDec 5, 2019GILLARD
EP3147292Labelled NucleotidesILLUMINA CAMBRIDGEJun 26, 2019HOFFMANN EITLE
EP2955190Chemical CompoundsNUCANADec 17, 2018GILEAD SCIENCES
EP3002289Modified Nucleotides For Polynucleotide SequencingILLUMINA CAMBRIDGENov 28, 2018HOFFMANN EITLE

To stay ahead in the competitive Nucleosides industry, companies are constantly innovating. Here are the top patents facing oppositions in the Nucleosides industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Patent NumberGrant DateTitleApplicantTotal Oppositions
EP2682397Apr 19, 2017Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making SameGILEAD SCIENCES3
EP2338893Dec 25, 2019Labelled NucleotidesILLUMINA CAMBRIDGE2
EP2896397Oct 7, 2020Novel Compounds Having Inhibitory Activity Against Sodium-Dependant Glucose TransporterMITSUBISHI TANABE PHARMA2
EP3002289Feb 28, 2018Modified Nucleotides For Polynucleotide SequencingILLUMINA CAMBRIDGE2
EP3147292Sep 26, 2018Labelled NucleotidesILLUMINA CAMBRIDGE1
EP3363809Apr 8, 2020Modified Nucleotides For Polynucleotide SequencingILLUMINA CAMBRIDGE1
EP3438116Feb 17, 2021Labelled NucleotidesILLUMINA CAMBRIDGE1
EP1633766Mar 6, 2019Modified Fluorinated Nucleoside AnaloguesGILEAD PHARMASSET1
EP3587433Apr 22, 2020Modified NucleotidesILLUMINA CAMBRIDGE1
EP2399588Apr 29, 2020Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral PolymeraseMERCK SHARP & DOHME1